Aisling Capital Management LP

Q3 2025 13F-HR Holdings

Location
New York, NY
Holdings as of
9/30/2025
Date filed
11/12/2025
Form type
13F-HR
Num holdings
14
Total value ($000)
$456,447
Net value change ($000)
+96,775 (26.9%)
New positions
2
Sold out positions
1
Turnover %
2.3%
Sector allocation + QoQ delta (equities-only)
Prev filing: 8/13/2025 Next filing: 2/10/2026 SEC filing

Snapshot: Change Analysis

Compared to Q2 2025
Methodology: sector metrics are equities-only; instrument mix chart is ex-options; options exposure is shown separately. Why this matters.
Top Adds (Value $000, Stocks/ETFs)
BBIO 54,272 20.7%
SNDX 7,941 64.4%
VRNA 7,464 12.8%
BBOT 6,538 NEW
NUVB 5,999 121.1%
GLUE 4,270 64.3%
BCAX 3,698 70.0%
CMPS 3,511 104.6%
SRRK 2,869 NEW
CALC 769 92.2%
Top Reduces (Value $000, Stocks/ETFs)
Elevation Oncology, Inc. -1,041 -100.0%
MRKR -208 -41.8%
Instrument mix + QoQ Δ (ex-options)
How this table is calculated: SEC VALUE ($000) is used as reported. For derivatives (PUT/CALL/WARRANT/RIGHT), SEC value represents reported underlying exposure, not premium cash paid/received. Column % is bucket-based: non-options share is calculated inside non-option total, options share is calculated inside options total. Details.
Filter:
Instrument:
Issuer Name Ticker Sector Industry Class History Value ($000) % Shares Shares Δ Shares Δ% Value Δ ($000) Value Δ% Principal Option Type